MedTrace Logo

Quiting Marijuana Use: Self-report Study of Quitting Straegies and Withdrawal Symptoms

NCT01603992 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 822

Last updated 2018-04-05

No results posted yet for this study

Summary

Background:

\- Marijuana is the most widely used illicit drug in the world, yet relatively little is known about users who try to quit without formal treatment ( spontaneous quitting). Studies have suggested that there are some common strategies that many individuals use in spontaneous quitting, such as changing one s lifestyle or identity, reminding oneself of negative consequences, support from family and friends, and religion. However, more research is needed to determine potential treatment strategies for marijuana use.

Objectives:

* To identify strategies used to help with marijuana quitting among non-treatment seeking adult marijuana users.
* To identify withdrawal symptoms experienced during marijuana quitting and their relationship to the quitting strategies used and the outcome of the quit attempt.
* To evaluate whether subgroups of marijuana users differ in their experience of marijuana quitting.

Eligibility:

\- Individuals at least 18 years of age who have made at least one attempt to quit marijuana use.

Design:

* The study will consist of one visit of approximately 1 to 2 hours.
* Participants will fill out three questionnaires. The questionnaires have different types of questions, and will ask about background and lifestyle, marijuana use and craving patterns and behaviors, and difficulties in previous attempts to quit using marijuana.

Conditions

  • Cannabis Abuse
  • Cannabis Dependence

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    lead NIH

Principal Investigators

  • David A Gorelick, M.D. · National Institute on Drug Abuse (NIDA)

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-11-08
Completion
2012-05-03

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01603992 on ClinicalTrials.gov